As the global economy mends, the 2021 growth of Topical Absorbable Hemostat will have significant change from previous year. According to our (LP Information) latest study, the global Topical Absorbable Hemostat market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Topical Absorbable Hemostat market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Topical Absorbable Hemostat market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Topical Absorbable Hemostat market, reaching US$ million by the year 2028. As for the Europe Topical Absorbable Hemostat landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Topical Absorbable Hemostat players cover 3-D Matrix Ltd, Angiotech Pharmaceuticals Inc, Anika Therapeutics Inc, and APRUS Bio-Medical Innovations Pvt Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Topical Absorbable Hemostat market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Combination Hemostats – Pads
Oxidized Regenerated Cellulose Based Hemostats
Polysaccharide Based Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Surgery
First-aid
Health Care
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
3-D Matrix Ltd
Angiotech Pharmaceuticals Inc
Anika Therapeutics Inc
APRUS Bio-Medical Innovations Pvt Ltd
Arch Therapeutics Inc
Baxter
C.R. Bard
Cellphire Inc
Covalon Technologies Ltd
Cresilon Inc
Endomedix Incorporated
Entegrion Inc
Ethicon
ETX Pharma Inc
Gelita
Pfizer